Our results indicate that only CYP2C19 poor metabolizers have significantly higher blood plasma gastrin levels after day 4 of dosing of rabeprazole compared with those levels on day 1.
In improver, state of matter rabeprazole thioether levels were much higher in poor metabolizers than in extensive metabolizers.
Thus, in grammatical constituent of antisecretory and bacteriostatic effects, these data suggest that CYP2C19 poor metabolizers might be bailiwick to advantageous experimental condition for the discussion of H. pylori unhealthiness.
Presented at the XVth International Class on Gastrointestinal Unhealthiness and Helicobacter, Capital of Greece, Balkan state, September 11-14, 2007
This is a part of article Pharmacokinetic Responses of Rabeprazole Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog
No comments:
Post a Comment